Physician profile
Teddy D Shields
NPI 1972666147
$2,398.08
in general payments reported to CMS, 2019-2025
21 companies · $793 in 2025
The $793 reported for 2025 was more than what a typical Interventional Pain Medicine provider received nationally (typical 2025 total: $676).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $23.66 · 2020: $40.05 · 2021: $221 · 2022: $226 · 2023: $122 · 2024: $972 · 2025: $793.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,705 · Travel and Lodging: $182.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,704.92 |
| Travel and Lodging | $182.25 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $920.88 | 2021-2025 | Intellis Adaptivestim, Inceptiv, Accurian |
| Boston Scientific Corporation | $608.18 | 2024-2025 | Intracept, Wavewriter Alpha Prime 16 |
| Abbvie INC. | $194.45 | 2021-2024 | Qulipta, Ubrelvy |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $140.39 | 2019-2025 | Relistor |
| Stryker Corporation | $92.78 | 2025 | Spinejack |
| Si-Bone, INC. | $60.29 | 2024-2025 | |
| Allergan, INC. | $58.91 | 2022 | |
| Nevro Corp. | $43.73 | 2020-2021 | |
| Grt US Holding, INC. | $32.89 | 2021-2022 | |
| Pacira Therapeutics, INC. | $32.28 | 2021 | |
| Lilly USA, LLC | $26.84 | 2020-2021 | |
| Abbott Laboratories | $26.35 | 2025 | Eterna |
| Averitas Pharma INC. | $22.99 | 2024 | Qutenza |
| Painteq LLC | $22.08 | 2024 | Painteq |
| Amgen INC. | $21.72 | 2022 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Collegium Pharmaceutical, INC. | $19.07 | 2021 | |
| Nalu Medical, INC. | $17.33 | 2022 | |
| Globus Medical, INC. | $15.33 | 2025 | Vyrsa V1 |
| Forte Bio-Pharma LLC | $15.21 | 2021 | |
| Scilex Pharmaceuticals INC. | $14.09 | 2021 | |
| Novo Nordisk INC | $12.29 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Teddy Shields listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.